Cargando…

The UK national breast cancer screening programme for survivors of Hodgkin lymphoma detects breast cancer at an early stage

BACKGROUND: Supradiaphragmatic radiotherapy (SRT) to treat Hodgkin's lymphoma (HL) at a young age increases the risk of breast cancer (BC). A national notification risk assessment and screening programme (NRASP) for women who were treated with SRT before the age of 36 years was instituted in th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Howell, S J, Searle, C, Goode, V, Gardener, T, Linton, K, Cowan, R A, Harris, M A, Hopwood, P, Swindell, R, Norman, A, Kennedy, J, Howell, A, Wardley, A M, Radford, J A
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2009
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2736813/ https://www.ncbi.nlm.nih.gov/pubmed/19672261 http://dx.doi.org/10.1038/sj.bjc.6605215

Ejemplares similares

Likely uptake of a future a lung cancer screening programme in Hodgkin lymphoma survivors: a questionnaire study
por: Broadbent, Rachel, et al.
Publicado: (2022)

Psychiatric morbidity in patients with advanced cancer of the breast: prevalence measured by two self-rating questionnaires.
por: Hopwood, P., et al.
Publicado: (1991)

Screening for psychiatric morbidity in patients with advanced breast cancer: validation of two self-report questionnaires.
por: Hopwood, P., et al.
Publicado: (1991)

Perception of risk in women with a family history of breast cancer.
por: Evans, D. G., et al.
Publicado: (1993)

P067: A pilot of lung cancer screening for survivors of Hodgkin lymphoma
por: Broadbent, Rachel, et al.
Publicado: (2022)

The impact of genetic counselling on risk perception in women with a family history of breast cancer.
por: Evans, D. G., et al.
Publicado: (1994)

Incidence of cerebral metastases in patients treated with trastuzumab for metastatic breast cancer
por: Clayton, A J, et al.
Publicado: (2004)

Measuring the impact of cancer: a comparison of non-Hodgkin lymphoma and breast cancer survivors
por: Crespi, Catherine M., et al.
Publicado: (2009)

High incidence of late effects found in Hodgkin's lymphoma survivors, following recall for breast cancer screening
por: Greenfield, D M, et al.
Publicado: (2006)

Risk of second breast cancer in female Hodgkin’s lymphoma survivors: a meta-analysis
por: Ibrahim, Ezzeldin M, et al.
Publicado: (2012)

Effect of intermittent versus chronic energy restriction on breast cancer risk biomarkers in premenopausal women: a randomised pilot trial
por: Harvie, M, et al.
Publicado: (2006)

The effect of intermittent versus chronic energy restriction on breast cancer risk biomarkers in premenopausal women: a randomised pilot trial
por: Harvie, M, et al.
Publicado: (2008)

Detection and Treatment of Early Breast Cancer
por: Howell, A.
Publicado: (1991)

T064: Doxorubicin exposure and breast cancer risk in adolescent and adult Hodgkin lymphoma survivors
por: Neppelenbroek, Suzanne I.M., et al.
Publicado: (2022)

Radiation-induced breast cancer: the question of early breast cancer screening in Hodgkin's lymphoma survivors
por: Hilal, Talal, et al.
Publicado: (2016)

The use of granulocyte colony-stimulating factor to increase the intensity of treatment with doxorubicin in patients with advanced breast and ovarian cancer.
por: Bronchud, M. H., et al.
Publicado: (1989)

A comparison of the metastatic pattern of infiltrating lobular carcinoma and infiltrating duct carcinoma of the breast.
por: Harris, M., et al.
Publicado: (1984)

Second primary breast cancer after Hodgkin's disease
por: Horwich, A, et al.
Publicado: (2004)

Breast cancer risk following Hodgkin lymphoma radiotherapy in relation to menstrual and reproductive factors
por: Cooke, R, et al.
Publicado: (2013)

DNA analysis by flow cytometry, response to endocrine treatment and prognosis in advanced carcinoma of the breast.
por: Baildam, A. D., et al.
Publicado: (1987)

A follow-up study of breast and other cancers in families of an unselected series of breast cancer patients
por: Bennett, K E, et al.
Publicado: (2002)

The future of breast cancer prevention
por: Howell, A, et al.
Publicado: (2005)

Variation of receptor status in cancer of the breast.
por: Harland, R. N., et al.
Publicado: (1983)

The development of a decision aid to support Hodgkin lymphoma survivors considering lung cancer screening
por: Broadbent, Rachel, et al.
Publicado: (2022)

Flexible care in breast cancer
por: Wardley, A., et al.
Publicado: (2021)

Tumour markers in breast cancer.
por: Cove, D. H., et al.
Publicado: (1979)

Cancer experience in the relatives of an unselected series of breast cancer patients.
por: Teare, M. D., et al.
Publicado: (1994)

Breast cancer detection among young survivors of pediatric Hodgkin lymphoma with screening magnetic resonance imaging
por: Tieu, Minh Thi, et al.
Publicado: (2014)

Metaplastic breast cancer and BRCA1: first strong evidence of a link
por: Evans, D. Gareth R, et al.
Publicado: (2023)

Risk of non-Hodgkin lymphoma in breast cancer survivors: a nationwide cohort study
por: Kang, Danbee, et al.
Publicado: (2021)

Risk of breast cancer according to clinicopathologic features among long-term survivors of Hodgkin's lymphoma treated with radiotherapy
por: Dores, G M, et al.
Publicado: (2010)

The globalisation of breast cancer
por: Boyle, Peter, et al.
Publicado: (2010)

The clinical value of immunohistochemically demonstrable CEA in breast cancer: a possible method of selecting patients for adjuvant chemotherapy.
por: Smith, S. R., et al.
Publicado: (1982)

Interval cancers in the Dutch breast cancer screening programme
por: Fracheboud, J, et al.
Publicado: (1999)

Reduction in calcium excretion in women with breast cancer and bone metastases using the oral bisphosphonate pamidronate.
por: Dodwell, D. J., et al.
Publicado: (1990)

Breast cancer risk-assessment models
por: Evans, D Gareth R, et al.
Publicado: (2007)

Treatment of HER2-positive metastatic breast cancer with lapatinib and capecitabine in the lapatinib expanded access programme, including efficacy in brain metastases – the UK experience
por: Sutherland, S, et al.
Publicado: (2010)

Estrogenicity of essential oils is not required to relieve symptoms of urogenital atrophy in breast cancer survivors
por: Simões, Bruno M., et al.
Publicado: (2018)

Metabolic approaches to breast cancer treatment and prevention
por: Howell, Anthony
Publicado: (2007)

Managing Breast Cancer Risk
por: Ong, Kai Ren, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_2nqo41r1auuopmsmpcmliui96h